You are here

New Funding Opportunity from NIDA

Tuesday, June 20, 2017

HIV/HCV Co-Infections in Substance Abusers (R01)
Funding Type: NIDA
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Release Date: June 13, 2017
Due Date: September 7 2017 and January 7, 2018 , by 5:00 PM local time of applicant organization.
Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to fill gaps in our understanding of (a) the impact of substance abuse on HIV, HIV/HCV co-infection associated disease progression, (b) the pathogenic interactions between HIV and hepatitis C virus, (c) hepatic and non-hepatic co-morbidities associated with HIV/HCV-co-infections in people with substance abuse disorders (SUDs), and (d) the effectiveness of interferon-free direct acting antiviral (DAAs) drug regimens to treat HIV/HCV co-infections in people with SUDs. This FOA is informed by priority area in the NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding: and the HHS National Viral Hepatitis Action Plan 2017-2020: